Month: May 2022
CARLSBAD, Calif., May 24, 2022 (GLOBE NEWSWIRE) — AppTech Payments Corp. (“AppTech”) (NASDAQ: APCX), a Fintech company powering commerce experiences, is excited to announce the closing of its acquisition of Hothand Inc. (“Hothand”), a patent holding company that owns the intellectual property rights to a patent portfolio that broadly covers geofence triggered ecommerce and/or advertising via cell phone.
The purchase price was a combination of cash and stock, to be disbursed upon predetermined revenue milestones.
AppTech now owns Hothand’s portfolio of twelve patents including USPTO 7,693,752; USPTO 8,554,632; USPTO 8,799,102; USPTO 9,436,956; USPTO 10,102,556; USPTO 10,127,592; USPTO 10,600,094; USPTO 10,621,639; USPTO 10,846,726; USPTO 10,846,727; USPTO 10,909,593; USPTO 11,107,140. These patents are focused...
MannKind’s Technosphere® Inhalation Platform Utilized in FDA-Approved Tyvaso DPI™
Written by Customer Service on . Posted in Public Companies.
MannKind celebrates that the FDA has approved United Therapeutics’ Tyvaso DPI™ (treprostinil) inhalation powder
Tyvaso DPI™ production is underway at MannKind Corporation (Nasdaq: MNKD) in Danbury, Conn. On May 24, 2022, MannKind celebrated that the U.S. Food and Drug Administration (FDA) has approved United Therapeutics’ Tyvaso DPI™ (treprostinil) inhalation powder. Tyvaso DPI represents the second FDA-approved product utilizing MannKind’s innovative Technosphere® inhalation technology. MannKind and United Therapeutics (Nasdaq: UTHR) entered into a worldwide exclusive licensing and collaboration agreement in September 2018 for the development and commercialization of Tyvaso DPI.Tyvaso DPI represents the second FDA-approved product utilizing MannKind’s Technosphere® inhalation technology
First approval of a dry powder inhaled treatment...
HONKARAKENNE OYJ REINSTATES ITS FINANCIAL GUIDANCE FOR 2022
Written by Customer Service on . Posted in Public Companies.
HONKARAKENNE OYJ Insider information May 24, 2022 at 13:00
HONKARAKENNE OYJ REINSTATES ITS FINANCIAL GUIDANCE FOR 2022
At the meeting held on May 23, 2022, Honkarakenne Oyj’s Board of Directors decided to issue new financial guidelines for 2022. Honkarakenne Oyj withdrew its financial guidance for 2022 in a stock exchange release on March 1, 2022 due to the uncertainty caused by the war in Ukraine and the suspension of sales in Russia. Honkarakenne Oyj’s outlook for the rest of the year has become clearer and this allows restoring the guidance for the year 2022.
At its meeting on May 23, 2022, the Board of Directors decided to reinstate its financial guidance.
New guidance for 2022
Honkarakenne’s outlook is that revenue (net sales) will increase from the previous year and profit before taxes will be at the previous...
Constellium Posts Annual Ordinary General Meeting Materials
Written by Customer Service on . Posted in Public Companies.
PARIS, May 24, 2022 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) (the “Company”) today announced that the notice and agenda and other documents for the Company’s Annual Ordinary General Meeting of Shareholders to be held on June 10, 2022, at 16:00 CET (10:00 AM EDT), are available on its website at www.constellium.com and will be available free of charge at the offices of the Company by contacting the Corporate Secretary at cstm.corporatesecretary@constellium.com.
About Constellium
Constellium (NYSE: CSTM) is a global sector leader that develops innovative, value added aluminium products for a broad scope of markets and applications, including aerospace, automotive and packaging. Constellium generated €6.2 billion of revenue in 2021.Jason Hershiser – Investor RelationsPhone: +1 443 988 0600investor-relations@constellium.com
Delphine...
Verde Announces Plans for First Distribution of Gains and Restructure
Written by Customer Service on . Posted in Public Companies.
Return Expected to Be a Minimum of C$10 Million to Shareholders for FY 2022 While Keeping a Minimum of C$30 Million in the Company, Restructure Expected to Increase Markets for Verde
BELO HORIZONTE, Brazil, May 24, 2022 (GLOBE NEWSWIRE) — Verde AgriTech Plc (TSX: “NPK”) (OTCQB: “AMHPF”) (“Verde” or the “Company”) is pleased to announce the findings of the Independent Special Committee of the Board of Directors (the “Committee”) to re-domicile Verde to Singapore (the “Re-domiciliation”) to deliver commercial freedoms and benefits. The Committee believes the Re-domiciliation is in the best interests of Verde’s future commercial success, with access to new markets, while helping in the implementation of the Paid for Growth (“P4G”) strategy, a cornerstone program aimed at distributing gains to shareholders while maintaining Verde’s...
Check Point Software Technologies Achieves New Common Criteria Certification to Meet the Security Requirements for Governments Worldwide
Written by Customer Service on . Posted in Public Companies.
Check Point Quantum Network Security R81 receives a common criteria certification in compliance with approved community Protection Profiles
SAN CARLOS, Calif., May 24, 2022 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cyber security solutions globally, is proud to announce the successful completion of a new Common Criteria (CC) certification. This achievement marks the important recognition of Check Point’s ability to meet or exceed the security requirements of the 31 Nations who are members of the Common Criteria Recognition Agreement (CCRA). Purchase decisions by Government and closely related industry, including critical infrastructure often require certification through Common Criteria.
Common Criteria certification is recognized by Governments around the world as the standard...
FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years
Written by Customer Service on . Posted in Public Companies.
– EFFICACY: In the pivotal Phase 3 clinical trial program, VTAMA cream met all primary and secondary endpoints and demonstrated highly statistically significant improvement versus vehicle in Physician Global Assessment (PGA) score with 36% of patients versus 6% in vehicle in PSOARING 1 and 40% of patients versus 6% in vehicle in PSOARING 2 achieving clear or almost clear with a minimum 2-grade improvement at week 12 (p
Jourdan Completes Phase 2 of its 2022 Drilling Program
Written by Customer Service on . Posted in Public Companies.
Figure 1
The Vallée property is immediately east of the North American Lithium mine. This figure depicts the 2011, 2021 and 2022 completed drillholes. All 26 drillholes since 2021 have intersected the li-bearing, spodumen-rich pegmatite swarm.All eighteen holes of its 2022 winter drilling campaign have intersected the new spodumene-bearing pegmatite swarm.
TORONTO, May 24, 2022 (GLOBE NEWSWIRE) — JOURDAN RESOURCES INC. (TSXV: JOR; OTCQB: JORF, FRA:2JR1) (“Jourdan” or the “Company“) is pleased to announce that all of its eighteen (18) drill holes of its 2022 winter drilling campaign have intersected the new spodumene-bearing pegmatite swarm on its Vallée property at a previously underexplored eastern extension, which had not been exposed by the North American Lithium mine to the west of Vallée (see Fig. 1).
Jourdan is pleased...
CareDx Receives CE Mark for AlloSeq HCT for Use in Hematopoietic Cell Transplantation
Written by Customer Service on . Posted in Public Companies.
CareDx Expands Transplant Portfolio in Europe
SOUTH SAN FRANCISCO, Calif., May 24, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it has received CE marking for its AlloSeq HCT chimerism testing kit and AlloSeq HCT interpretation software for use in patients who have received hematopoietic cell transplantation (HCT).
“Transplantation is global and CareDx is proud to expand its leadership in Europe with CE marked AlloSeq HCT to help improve care for hematopoietic cell transplant patients,” said Reg Seeto, CEO and President of CareDx. “This new CE mark demonstrates our commitment to bringing high quality products to...
iMedia Brands, Inc. Reports First Quarter 2022 Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Q1 Net Sales were $155 Million, a 37% Increase Over the Prior Year Period
MINNEAPOLIS, May 24, 2022 (GLOBE NEWSWIRE) — iMedia Brands, Inc. (“iMedia”) (NASDAQ: IMBI, IMBIL) today announced results for the first quarter ended April 30, 2022.
“We are off to good start this year,” said Tim Peterman, CEO of iMedia. “Our top three fiscal 2022 priorities continue to be to deliver positive earnings per share in the fourth quarter, strengthen our balance sheet, and capitalize on the convergence of entertainment, advertising and ecommerce.”
First Quarter 2022 Consolidated Highlights:Net sales were $155 million, a 37% increase over the prior year period.
Gross margin was 39.7%, a 96 basis-point decline from the prior year period.
Net loss was $11.9 million or $(0.55) per common share, compared to $3.2 million or $(0.21) per common share...
